Polyethylene Glycol 3350 Increases Frequency Of Bowel Movements And Softens Stools
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Kesin Pharma Corporation for the product Polyethylene Glycol 3350 (NDC 81033-762). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding polyethylene glycol 3350 increases frequency of bowel movements and softens stools, active ingredient (in each dose), purpose, use, allergy alert:, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are taking, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Polyethlene Glycol 3350, 17 g
Osmotic Laxative
Do not use if you are allergic to polyethylene glycol
if you have kidney disease, except under the advice and supervision of a doctor
a prescription drug
you may have loose, watery, more frequent stools
ask a health professional before use.
Keep out of the reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
none
Call 1-833-537-4679
| TAMPER-EVIDENT: DO NOT USE IF PRINTED FOIL POUCH IS OPEN OR BROKEN |
*This product is not manufactured by Bay HealthCare LLC, owner of the registered trademark MiraLAX ®
Distributed by:
Kesin Pharma
Oldsmar, FL 34677
NDC 81033-762-14
Polyethylene Glycol 3350 Powder for Oral Solution
Osmotic Laxative
14 Packets
(14 once-daily-doses)
NDC 81033-762-30
Polyethylene Glycol 3350 Powder for Oral Solution
Osmotic Laxative
30 Packets
(30 once-daily doses)
NDC 81033-762-01
Polyethylene Glycol 3350 Powder for Oral Solution
Osmotic laxative
100 Packets
(100 once-daily doses)
* Please review the disclaimer below.